Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 145 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Rivaroxaban for prevention of cardiovascular events following an episode of decompensated heart failure	Rivaroxaban (Xarelto; BAY 59-7939)	Heart failure (HF)	Cardiovascular System	2018	View \| Download
Rituximab for Pemphigus Vulgaris	Rituximab (MabThera; Rituxan; RG 105)	Pemphigus vulgaris	Dermatology , Immunology	2018	View \| Download
Rimegepant for the treatment of Acute Migraine	Rimegepant (Zydis; BHV3000; Nurtec)	Migraine	Neurology	2018	View \| Download
Refanalin for Delayed Graft Function Following Kidney Transplant	Refanalin (BB-3; ANG-3777)	Delayed graft function (DGF)	Nephrology	2018	View \| Download
RBX-2660 for the Treatment of Recurrent Clostridium Difficile Infection – third line	RBX-2660	Clostridioides difficile infection	Infectious Disease	2018	View \| Download
Ravulizumab for atypical haemolytic uraemic syndrome in adults and children – first line	Ravulizumab (ALXN1210; Ultomiris)	Atypical haemolytic uraemic syndrome (aHUS)	Haematology , Nephrology	2018	View \| Download
Ranibizumab for Retinopathy of Prematurity – first line	Ranibizumab (Lucentis Port Delivery System; Lucentis)	Retinopathy of prematurity	Gynaecology and Obstetrics , Ophthalmology	2018	View \| Download
Ranibizumab for proliferative and non-proliferative diabetic retinopathy	Ranibizumab (Lucentis Port Delivery System; Lucentis)	Diabetic retinopathy	Endocrine Nutritional and Metabolic Disorders , Ophthalmology	2018	View \| Download
Ramucirumab for Advanced Hepatocellular Carcinoma – second line	Ramucirumab (Cyramza)	Hepatocellular carcinoma (HCC)	Gastrointestinal Cancer	2018	View \| Download
PXT3003 for Charcot-Marie-Tooth Disease Type 1A	PXT-3003 (fixed dose combination: baclofen; Naltrexone hydrochloride; sorbitol)	Charcot-Marie-Tooth disease	Genetic Disorders , Neurology	2018	View \| Download